Compugen Ltd. (CGEN) Announces Addition Of Prof. Drew Pardoll To Its Scientific Advisory Board
1/21/2014 6:28:12 AM
Genetics at Johns Hopkins University of Medicine, has joined Compugen’s Scientific Advisory Board (SAB). The SAB, disclosed in August 2013, provides insight and guidance on the Company’s activities in the fields of oncology and immunology with particular emphasis on its early stage pipeline of therapeutic proteins and monoclonal antibodies, largely based on Compugen-discovered immune checkpoint protein candidates.
Help employers find you! Check out all the jobs and post your resume.